To further investigate the immunogenic properties of DACT, we treated cancer cells in vitro with this compound, labeled them with CellTracker orange (CMTMR) and measured their engulfment by bone marrow‐derived CD11c+ dendritic cells (BMDCs) (Fig 4A). The gene discussed is ITGAX; the disease is cancer.